Clinical trial
Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal…
NCT00172809 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00172809 |
|---|---|
| Title | Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease |
| Official title | A Pilot Study in Comparing the Efficacy and Safety of Peginterferon Alfa-2a and Interferon Alfa-2a in Treating Patients With End Stage Renal Disease and Chronic Hepatitis C |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | Peginterferon alfa-2a, Interferon alfa-2a |
| Enrollment | 50 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 6, 2008 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: